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ABSTRACT
Stiff person syndrome (SPS) is a rare neurological disorder characterized by progressive muscle stiffness and rigidity,
mostly involving axial muscles, resulting in functional disability. It is associated with elevated anti- Glutamic acid decarboxylase (GAD) antibody levels. Electromyography findings are often diagnostic. We present a case of a 48 years old
male, who presented with progressive stiffness and rigidity of axial muscles and limbs. His EMG was consistent with
SPS. Anti GAD antibodies were markedly elevated. He was treated with rituximab and has improved significantly. SPS
is a difficult diagnosis, usually under diagnosed due to lack of awareness among medical community. There is a dire
need to further study the disease and invent better treatment options for patients suffering from SPS.
CASE REPORT

Anti-GAD antibodies were sent which were found to be
markedly elevated to a level of > 2000IU/mL. To further
confirm our diagnosis, Electromyography (EMG) was
done, which showed continuous motor activity in agonist
and antagonists muscles, subsiding on the administration of Intravenous diazepam 5 mg (Figure 1).

A 48 year old male, known case of Type l Diabetes Mellitus
and depression, presented to Neurology Outpatient department with complaints of progressive pain and stiffness of
neck, shoulder and abdominal muscles for the past six
months. The pain and spasm aggravated with stress and
movement and was temporarily relieved on taking Non
steroidal anti-inflammatory drugs and muscle relaxants.
Initially he did not have any disability and despite stiffness
he was able to carry out his daily life activity. However, the
stiffness worsened over time, resulting in difficulty in walking
and performing daily tasks. Physical examination revealed
stiffness over muscles of neck, shoulder and abdominal
regions. He had a robot like gait. Rest of the neurological
examination, including cranial nerves, motor and sensory
examination, was unremarkable. Based on the history and
physical examination he appeared to be suffering from stiff
person syndrome. The pertinent baseline investigations
were normal (Table 1).
Table 1: Pertinent baseline investigations
Laboratory Investigation
CRP
ESR
Calcium
25 Hydroxy Vitamin D
TSH
CPK
Aldolase
X-Ray Lumbo-sacral spine
MRI brain with contrast

Figure1a

Results
2.35 U/L
2 mm 1st hr
9.4 mg/dL
36.2 ng/mL
2.18 micro IU/L
199 U/L
7.0 U/L
Unremarkable
Normal
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Figure 1: EMG showing a) continuous motor activity
which b) subsided on giving 5 mg IV diazepam.
The patient was treated with Diazepam 2.5mg PO qHS
and Baclofen 5mg three times daily. On a two week
follow up visit, the patient showed improvement in pain,
stiffness and functional status. A Rheumatology consult
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was sought regarding the disease modifying treatment
options, and Rituximab infusion was advised after
screening for Hepatitis B and C.

The exact cause of the disease is yet unknown. Most
patients with classical SPS have antibody against
Glutamic acid decarboxylase (GAD), an enzyme that
plays a vital role in the regulation of an important inhibitory neurotransmitter of Central nervous system, gamma
amino butyric acid (GABA) .Destruction of the GAD
enzyme results in less availability of GABA neurotransmitter and hence, leads to excessive stimulation of the
muscles by motor neurons causing muscle stiffness (4).
SPS is a clinical diagnosis, confirmed using Electromyography (EMG). EMG of patients with SPS shows continuous motor activity which can be suppressed by diazepam.
This is a confirmatory test (5). Anti GAD antibodies are
also checked in patients suspected for SPS. In approximately 85% of patients with SPS have high titers of anti
GAD antibodies (6). There is a strong suspicion of an association between SPS and other autoimmune diseases.
SPS is more commonly seen in patients with insulin
dependent diabetes mellitus, thryoiditis, paraneoplastic
syndromes and epilepsy (7). SPS has no permanent cure.
However two therapeutic strategies have been tried for
patients with SPS. First includes the use of GABA
enhancing medications for symptomatic relief by
decreasing muscle stiffness. Baclofen and benzodiazepines are most commonly used drugs for this purpose.
These drugs increase GABA activity and hence alleviate
muscle stiffness (8).The second approach is to use
disease modifying agents like rituximab and intravenous
immunoglobulin to decrease the progression of the
disease (9). Both treatment approaches along with physical and occupations therapy should be used in patients
for ultimate favorable results. The role of steroids and
plasma exchange is still questionable. New trials are
being conducted to study the role of rituximab in patients
with stiff person syndrome. According to the studies
conducted so far, clinical improvement has been seen in
patients using rituximab especially in those who did not
respond well to traditional therapy (10). Further studies are
needed before it could become an established drug of
choice for SPS.

Figure1b
He was given a total of three doses of Rituximab infusion
500mg in 500ml of normal saline over 2 to 3 hours,
each one week apart. He was pre-medicated with Injection Methylprednisolone 100mg diluted in 500mL of
Normal saline given intravenously along with two tablets
of acetaminophen 500mg per orally and Injection chlorphenamine 10mg Intravenously. Complete blood count,
Liver function tests, Blood urea nitrogen and creatinine
were checked after the administration of first and third
dose and were normal. Anti GAD antibodies will be
re-checked after two months.
DISCUSSION
Stiff person syndrome (SPS) is a rare neurological disorder characterized by fluctuating muscle rigidity of trunk
and limbs resulting in abnormal postures (1). Muscle
rigidity and episodic spasms result in functional disability
of the patients. This rare neurological disorder was first
described by Moersch and Woltman in 1956 (2). A Dalakas criterion, as given below (Table 2) is the most widely
used scale for establishing the diagnosis of SPS (3).

CONCLUSION

Table 2. Dalakas Criteria

SPS is an under diagnosed neurological disorder. This is
due to lack of awareness of the disease among medical
community. In order to avoid delay in the treatment and
improve prognosis, early diagnosis is necessary. A
multi-disciplinary approach can help in diagnosing and
managing such patients.

Dalakas criteria for diagnosis stiff person syndrome
Episodic stiffness of the muscles, mostly involving the axial
muscles, leading fixed deformity
Superimposed painful spasms elicited by triggers such as noises,
emotional stress and tactile stimuli
Absence of neurological or cognitive impairment
Confirmation of continuous motor activity by electro-myographic
findings (EMG). (subsides with diazepam*)
Positive serology for GAD65 or amphiphysin autoantibodies
*not a part of Dalakas criteria, but commonly included in the
diagnostic criteria
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